234 related articles for article (PubMed ID: 24337417)
21. Post-bedtime dosing with indiplon in adults and the elderly: results from two placebo-controlled, active comparator crossover studies in healthy volunteers.
Farber RH; Burke PJ
Curr Med Res Opin; 2008 Mar; 24(3):837-46. PubMed ID: 18257978
[TBL] [Abstract][Full Text] [Related]
22. In the Zzz zone: the effects of Z-drugs on human performance and driving.
Gunja N
J Med Toxicol; 2013 Jun; 9(2):163-71. PubMed ID: 23456542
[TBL] [Abstract][Full Text] [Related]
23. Effects of after-midnight intake of zolpidem and temazepam on driving ability in women with non-organic insomnia.
Partinen M; Hirvonen K; Hublin C; Halavaara M; Hiltunen H
Sleep Med; 2003 Nov; 4(6):553-61. PubMed ID: 14607350
[TBL] [Abstract][Full Text] [Related]
24. Effect of zopiclone and temazepam on sleep EEG parameters, psychomotor and memory functions in healthy elderly volunteers.
Hemmeter U; Müller M; Bischof R; Annen B; Holsboer-Trachsler E
Psychopharmacology (Berl); 2000 Jan; 147(4):384-96. PubMed ID: 10672632
[TBL] [Abstract][Full Text] [Related]
25. Hypnotic discontinuation in chronic insomnia: impact of psychological distress, readiness to change, and self-efficacy.
Belleville G; Morin CM
Health Psychol; 2008 Mar; 27(2):239-48. PubMed ID: 18377143
[TBL] [Abstract][Full Text] [Related]
26. Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia.
Holm KJ; Goa KL
Drugs; 2000 Apr; 59(4):865-89. PubMed ID: 10804040
[TBL] [Abstract][Full Text] [Related]
27. The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: a systematic review and meta-analysis.
Stranks EK; Crowe SF
J Clin Exp Neuropsychol; 2014; 36(7):691-700. PubMed ID: 24931450
[TBL] [Abstract][Full Text] [Related]
28. The French addictovigilance network clinical assessment: Z-drugs, true false twins.
Rousselet M; Feuillet F; Gerardin M; Jolliet P; Hardouin JB; Victorri-Vigneau C
Expert Opin Drug Saf; 2017 Sep; 16(9):1063-1069. PubMed ID: 28649864
[TBL] [Abstract][Full Text] [Related]
29. New, Occasional, and Frequent Use of Zolpidem or Zopiclone (Alone and in Combination) and the Risk of Injurious Road Traffic Crashes in Older Adult Drivers: A Population-Based Case-Control and Case-Crossover Study.
Nevriana A; Möller J; Laflamme L; Monárrez-Espino J
CNS Drugs; 2017 Aug; 31(8):711-722. PubMed ID: 28669021
[TBL] [Abstract][Full Text] [Related]
30. Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam.
Gustavsen I; Bramness JG; Skurtveit S; Engeland A; Neutel I; Mørland J
Sleep Med; 2008 Dec; 9(8):818-22. PubMed ID: 18226959
[TBL] [Abstract][Full Text] [Related]
31. Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone.
Boyle J; Trick L; Johnsen S; Roach J; Rubens R
Hum Psychopharmacol; 2008 Jul; 23(5):385-97. PubMed ID: 18350566
[TBL] [Abstract][Full Text] [Related]
32. Is hypnotic withdrawal facilitated by the transitory use of a substitute drug?
Lemoine P; Ohayon MM
Prog Neuropsychopharmacol Biol Psychiatry; 1997 Jan; 21(1):111-24. PubMed ID: 9075261
[TBL] [Abstract][Full Text] [Related]
33. Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study.
Roehrs TA; Randall S; Harris E; Maan R; Roth T
J Psychopharmacol; 2012 Aug; 26(8):1088-95. PubMed ID: 22004689
[TBL] [Abstract][Full Text] [Related]
34. A double-blind comparative study of zolpidem versus zopiclone in the treatment of chronic primary insomnia.
Tsutsui S;
J Int Med Res; 2001; 29(3):163-77. PubMed ID: 11471853
[TBL] [Abstract][Full Text] [Related]
35. Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring.
Staner L; Ertlé S; Boeijinga P; Rinaudo G; Arnal MA; Muzet A; Luthringer R
Psychopharmacology (Berl); 2005 Oct; 181(4):790-8. PubMed ID: 16025317
[TBL] [Abstract][Full Text] [Related]
36. Independent sleep EEG slow-wave and spindle band dynamics associated with 4 weeks of continuous application of short-half-life hypnotics in healthy subjects.
Feige B; Voderholzer U; Riemann D; Hohagen F; Berger M
Clin Neurophysiol; 1999 Nov; 110(11):1965-74. PubMed ID: 10576495
[TBL] [Abstract][Full Text] [Related]
37. [Benzodiazepine-like hypnotics--attitudes and prescription practice among general practitioners].
Bachmann CS; Berg EA; Spigset O; Slørdal L
Tidsskr Nor Laegeforen; 2008 Jan; 128(2):166-70. PubMed ID: 18202726
[TBL] [Abstract][Full Text] [Related]
38. Are Seniors Dependent on Benzodiazepines? A National Clinical Survey of Substance Use Disorder.
Victorri-Vigneau C; Laforgue EJ; Grall-Bronnec M; Guillou-Landreat M; Rousselet M; Guerlais M; ; Feuillet F; Jolliet P
Clin Pharmacol Ther; 2021 Feb; 109(2):528-535. PubMed ID: 32860424
[TBL] [Abstract][Full Text] [Related]
39. Limited anxiolytic-like effects of non-benzodiazepine hypnotics in rodents.
Griebel G; Perrault G; Sanger DJ
J Psychopharmacol; 1998; 12(4):356-65. PubMed ID: 10065909
[TBL] [Abstract][Full Text] [Related]
40. Long-term use of zopiclone, zolpidem and zaleplon among Danish elderly and the association with sociodemographic factors and use of other drugs.
Andersen AB; Frydenberg M
Pharmacoepidemiol Drug Saf; 2011 Apr; 20(4):378-85. PubMed ID: 21259378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
